Note: Entrinsic Bioscience's revenues are gauged from an analysis of company filings.
Entrinsic Bioscience's Income Statement (based on Industry Averages)
Entrinsic Bioscience P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Entrinsic Bioscience is developing and marketing.
Entrinsic Bioscience doesn't have any recent trademark applications, indicating Entrinsic Bioscience is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
NOVARA PHARMACEUTICALS Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the modified release of a wide variety of therapeutic agents for treating cystic fibrosis, iron irregularities, diarrhea, constipation, short bowel syndrome, asthma, psoriasis, ulcerative colitis, celiac disease, tumors, irritable bowel diseases, environmental enteropathy disorder, atopic dermatitis, allergic rhinitis, Crohn's disease, hemochromatosis, iron deficiency anemia, and wounds
02/07/2020
NOVARX Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the modified release of a wide variety of therapeutic agents for treating cystic fibrosis, iron irregularities, diarrhea, constipation, short bowel syndrome, asthma, psoriasis, ulcerative colitis, celiac disease, tumors, irritable bowel diseases, environmental enteropathy disorder, atopic dermatitis, allergic rhinitis, Crohn's disease, hemochromatosis, iron deficiency anemia, and wounds
02/07/2020
NOVARARX Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the modified release of a wide variety of therapeutic agents for treating cystic fibrosis, iron irregularities, diarrhea, constipation, short bowel syndrome, asthma, psoriasis, ulcerative colitis, celiac disease, tumors, irritable bowel diseases, environmental enteropathy disorder, atopic dermatitis, allergic rhinitis, Crohn's disease, hemochromatosis, iron deficiency anemia, and wounds
02/07/2020
See all trademarks and details in the Full Report.
Market Share of Entrinsic Bioscience's Largest Competitors
A competitive analysis shows these companies are in the same general field as Entrinsic Bioscience, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Entrinsic Bioscience.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Entrinsic Bioscience and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
